<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Rebecca Spalding]]></title>
        <description><![CDATA[Rebecca Spalding]]></description>
        <link>https://www.bloomberg.com/authors/ASS6fqubiXk/rebecca-spalding</link>
        <generator>RSS for Node</generator>
        <lastBuildDate>Sun, 26 Apr 2026 10:01:07 GMT</lastBuildDate>
        <atom:link href="https://www.bloomberg.com/authors/ASS6fqubiXk/rebecca-spalding.rss" rel="self" type="application/rss+xml"/>
        <copyright><![CDATA[Copyright 2026 BLOOMBERG L.P. ALL RIGHTS RESERVED]]></copyright>
        <language><![CDATA[en]]></language>
        <item>
            <title><![CDATA[AbbVie Ends Work on Drug From $5.8 Billion Deal After Failures]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-08-29/abbvie-ends-work-on-drug-from-5-8-billion-deal-after-failures</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-08-29/abbvie-ends-work-on-drug-from-5-8-billion-deal-after-failures</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Thu, 29 Aug 2019 13:39:38 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iuajWZY.a6QM/v0/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iuajWZY.a6QM/v0/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>A technician prepares a sample inside a laboratory in Hong Kong. Photographer: Anthony Kwan/Bloomberg</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Hepatitis C Drugs Whose Prices Drew Criticism Get FDA Warning]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-08-28/hepatitis-c-drugs-whose-prices-drew-criticism-get-fda-warning</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-08-28/hepatitis-c-drugs-whose-prices-drew-criticism-get-fda-warning</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Wed, 28 Aug 2019 18:57:30 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/invhgWMn078Q/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/invhgWMn078Q/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>An automated machine works on purification of potential hepatitis C virus drug candidate at the Gilead Sciences Inc. lab in Foster City, California, U.S., on Wednesday, Feb. 8, 2012. Gilead acquired Pharmasset Inc. last month for its experimental hepatitis C treatments as it aims to compete with other drugmakers like Bristol-Myers Squibb Co. and Merck &amp; Co. to develop a new class of oral cures for hepatitis C to replace older drugs that require injections.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Amgen Will Buy Celgene Drug in $13.4 Billion Antitrust Sale]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-08-26/amgen-to-buy-celgene-s-psoriasis-drug-otezla-for-13-4-billion</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-08-26/amgen-to-buy-celgene-s-psoriasis-drug-otezla-for-13-4-billion</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Drew Armstrong]]></dc:creator>
            <pubDate>Mon, 26 Aug 2019 10:48:04 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i2C79i3VhYMA/v0/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i2C79i3VhYMA/v0/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Vials of medicine move along a conveyor on the production line at Guangzhou Pharmaceutical Holdings Ltd.&apos;s Baiyunshan plant in Guangzhou, China, on Monday, Oct. 30, 2017. Midea Group Co., the world&apos;s biggest appliance maker, is working with Guangzhou Pharmaceutical to bring fully-automated dispensaries that can pick, package and distribute pills at hospitals and drugstores. Photographer: Qilai Shen/Bloomberg</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[The FDA is flexing its muscles]]></title>
            <link>https://www.bloomberg.com/news/newsletters/2019-08-22/the-fda-is-flexing-its-muscles</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/newsletters/2019-08-22/the-fda-is-flexing-its-muscles</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Thu, 22 Aug 2019 19:00:04 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Some Patients’ Best Hope for a Cure Is to Develop It Themselves]]></title>
            <description><![CDATA[Ultra-rare diseases aren’t profitable for drug makers, so many sufferers go it alone]]></description>
            <link>https://www.bloomberg.com/news/articles/2019-08-21/some-patients-best-hope-for-a-cure-is-to-develop-it-themselves</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-08-21/some-patients-best-hope-for-a-cure-is-to-develop-it-themselves</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Wed, 21 Aug 2019 09:00:07 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iYd1uK5frY3M/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iYd1uK5frY3M/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Helen Evangelista and her son Matthew at St. Mary&apos;s Children&apos;s Hospital in New York, on Aug. 13.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Ebola Drug Shows Promising Results in Heart of Congo Outbreak]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-08-12/ebola-drug-shows-promising-results-in-heart-of-congo-outbreak</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-08-12/ebola-drug-shows-promising-results-in-heart-of-congo-outbreak</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Michelle Fay Cortez]]></dc:creator>
            <pubDate>Mon, 12 Aug 2019 14:59:46 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i64dqzbKSeb0/v2/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i64dqzbKSeb0/v2/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>A World Health Organization worker decontaminates the house of a pastor who has just tested positive for Ebola in Beni. </media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Biogen’s Good Quarter Delays Drugmaker’s Future Reckoning]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-07-23/biogen-shares-jump-after-biotech-giant-raises-full-year-forecast</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-07-23/biogen-shares-jump-after-biotech-giant-raises-full-year-forecast</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Tue, 23 Jul 2019 10:51:39 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Gilead to Boost Stake in Galapagos as Part of $5.1 Billion Deal]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-07-14/gilead-to-boost-stake-in-galapagos-as-part-of-5-1b-deal-wsj</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-07-14/gilead-to-boost-stake-in-galapagos-as-part-of-5-1b-deal-wsj</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Eric Pfanner]]></dc:creator>
            <pubDate>Sun, 14 Jul 2019 16:23:59 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i7jsvso57Nh0/v256/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i7jsvso57Nh0/v256/-1x-1.jpg"/>
                <media:description></media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Cancer Firm Lands One of Europe’s Biggest Biotech Funding Rounds]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-07-09/cancer-firm-lands-one-of-europe-s-biggest-biotech-funding-rounds</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-07-09/cancer-firm-lands-one-of-europe-s-biggest-biotech-funding-rounds</guid>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Tue, 09 Jul 2019 09:00:00 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iucjjUBEunIA/v0/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iucjjUBEunIA/v0/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description></media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Physicist and His Financier Brother Net $5 Billion Biotech IPO]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-06-28/physicist-and-his-financier-brother-net-5-billion-biotech-ipo</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-06-28/physicist-and-his-financier-brother-net-5-billion-biotech-ipo</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Fri, 28 Jun 2019 13:25:25 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iSKAia72UXxo/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iSKAia72UXxo/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Adaptive Biotechnologies Corp. IPO at the Nasdaq MarketSite on June 27.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Biotech’s moment of truth]]></title>
            <link>https://www.bloomberg.com/news/newsletters/2019-06-27/biotech-s-moment-of-truth</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/newsletters/2019-06-27/biotech-s-moment-of-truth</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Tim Annett]]></dc:creator>
            <pubDate>Thu, 27 Jun 2019 19:00:35 GMT</pubDate>
        </item>
        <item>
            <title><![CDATA[Abbvie Drops by a Record as Allergan Deal Fails to End Doubts]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-06-25/abbvie-in-63-billion-deal-to-buy-botox-maker-allergan</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-06-25/abbvie-in-63-billion-deal-to-buy-botox-maker-allergan</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Tue, 25 Jun 2019 10:48:44 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iu0Jep79EmCw/v253/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iu0Jep79EmCw/v253/-1x-1.jpg"/>
                <media:description></media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Bristol-Myers Will Divest Celgene Blockbuster to Close Deal]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-06-24/bristol-myers-will-divest-celgene-blockbuster-to-close-takeover</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-06-24/bristol-myers-will-divest-celgene-blockbuster-to-close-takeover</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Mon, 24 Jun 2019 11:29:45 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i4DbBH4TrFIc/v249/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i4DbBH4TrFIc/v249/-1x-1.jpg"/>
                <media:description></media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Bain Capital Raises $900 Million for Second Life-Sciences Fund]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-06-12/bain-capital-raises-900-million-for-second-life-sciences-fund</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-06-12/bain-capital-raises-900-million-for-second-life-sciences-fund</guid>
            <category><![CDATA[personal-finance]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Wed, 12 Jun 2019 10:00:00 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/it9lBCZOxEKk/v0/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/it9lBCZOxEKk/v0/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Chemicals sit inside a refrigerator at a lab in Cambridge, Massachusetts. Photographer: Adam Glanzman/Bloomberg</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Third Rock Ventures Raises $770 Million as Biotech Funds Thrive]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-06-06/third-rock-ventures-raises-770-million-as-biotech-funds-thrive</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-06-06/third-rock-ventures-raises-770-million-as-biotech-funds-thrive</guid>
            <category><![CDATA[personal-finance]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Thu, 06 Jun 2019 10:00:00 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i2puJr2OLKXY/v2/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i2puJr2OLKXY/v2/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>A technician handles a sample at a laboratory in Hong Kong, China. Photographer: Anthony Kwan/Bloomberg</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Bristol-Myers Borrows $19 Billion in Year's Biggest Bond Deal]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-05-07/bristol-myers-kicks-off-jumbo-bond-sale-to-fund-celgene-takeover</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-05-07/bristol-myers-kicks-off-jumbo-bond-sale-to-fund-celgene-takeover</guid>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Molly Smith]]></dc:creator>
            <pubDate>Tue, 07 May 2019 12:23:34 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iC2yRQKGtFuU/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iC2yRQKGtFuU/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Giovanni Caforio, chief executive officer of Bristol-Myers Squibb Co., speaks during a Bloomberg Television interview in New York, U.S., on Friday, March 8, 2019. Caforio discussed the drugmaker&apos;s deal for Celgene Corp. and new pharmaceutical developments from the combination.</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Blackstone Bets on Costly Drug Trials That Vex Even Big Pharma]]></title>
            <description><![CDATA[The private equity behemoth thinks its deep pockets can help drugmakers get new therapies to market.]]></description>
            <link>https://www.bloomberg.com/news/articles/2019-04-26/private-equity-giant-blackstone-bets-it-can-help-develop-drugs</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-04-26/private-equity-giant-blackstone-bets-it-can-help-develop-drugs</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Fri, 26 Apr 2019 09:00:14 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iLbhggiJ27x0/v251/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iLbhggiJ27x0/v251/-1x-1.jpg"/>
                <media:description></media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Migraine Drug Developer Biohaven Is Said to Explore Sale]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-04-12/migraine-drug-developer-biohaven-is-said-to-explore-sale</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-04-12/migraine-drug-developer-biohaven-is-said-to-explore-sale</guid>
            <category><![CDATA[world]]></category>
            <dc:creator><![CDATA[Cynthia Koons]]></dc:creator>
            <pubDate>Fri, 12 Apr 2019 15:32:36 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i.CxPlzR1Leg/v0/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i.CxPlzR1Leg/v0/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Headache Teenage Girl. (Photo by: Media for Medical/UIG via Getty Images) Photographer: Media for Medical/Universal Images Group Editorial</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Google's Venture Firm Taps Biotech Veteran in Life-Sciences Push]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-02-11/google-s-venture-firm-taps-biotech-veteran-in-life-sciences-push</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-02-11/google-s-venture-firm-taps-biotech-veteran-in-life-sciences-push</guid>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[science-energy]]></category>
            <dc:creator><![CDATA[Rebecca Spalding]]></dc:creator>
            <pubDate>Mon, 11 Feb 2019 14:00:00 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ikc.6OAsAqaw/v1/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ikc.6OAsAqaw/v1/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Signage for Google Ventures, the venture capital division of Google Inc, at the Googleplex, headquarters of Google Inc in the Silicon Valley town of Mountain View, California, April 7, 2017. (Photo via Smith Collection/Gado/Getty Images).</media:description>
            </media:content>
        </item>
        <item>
            <title><![CDATA[Biotech Alector Drops as IPOs Restart After U.S. Shutdown]]></title>
            <link>https://www.bloomberg.com/news/articles/2019-02-07/biotech-alector-raises-176-million-in-post-shutdown-ipo-restart</link>
            <guid isPermaLink="true">https://www.bloomberg.com/news/articles/2019-02-07/biotech-alector-raises-176-million-in-post-shutdown-ipo-restart</guid>
            <category><![CDATA[personal-finance]]></category>
            <dc:creator><![CDATA[Olivia Zaleski]]></dc:creator>
            <pubDate>Thu, 07 Feb 2019 01:11:38 GMT</pubDate>
            <media:content url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iXqRCTgCdBec/v0/piHJkQ_WoLj1E/-1x-1.jpg" type="image/jpeg">
                <media:thumbnail url="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iXqRCTgCdBec/v0/piHJkQ_WoLj1E/-1x-1.jpg"/>
                <media:description>Buildings stand on Wall Street near the New York Stock Exchange (NYSE) in New York, U.S. Photographer: John Taggart/                                                              </media:description>
            </media:content>
        </item>
    </channel>
</rss>